Federal government hampers research on marijuana as pain management medication, news reports find

Share this article:

The value of marijuana as a pain-management medication is still unclear as the government continues to discourage research into the effects of the drug, according to a pair of news items.

Fewer than 20 clinical trials have been performed investigating the potential benefits of smoking marijuana, The Wall Street Journal reported. What's more, the number of participants—roughly 300 between all the studies—is far too small to generate enough evidence to promote the drug's use. Other researchers who aim to unlock the possible pain-managing effects of marijuana have run into federal roadblocks, including resistance from the Drug Enforcement Agency, and reluctance on the part of the government to allow researchers to grow their own crops, according to a New York Times article.

The DEA has hampered pain management efforts in the past, affecting nursing homes across the country. The agency has recently begun more heavily enforcing rules that require written approvals from doctors. Many nursing home nurses view these and other rules from the DEA as a hindrance to their efforts at relieving pain among their patients.


Share this article:

More in News

Bulk of Medicaid to be managed care in two years: Avalere

Bulk of Medicaid to be managed care in ...

More than three-quarters of Medicaid beneficiaries will be enrolled in a managed care plan as of 2016, according to an Avalere Health analysis released Thursday. The numbers reveal that managed ...

Nursing home asked for employee's personal information too often, jury rules

The human resources department of a Maine nursing home did not properly protect a former employee's personal identification information, a jury recently ruled.

Test could confirm sepsis within an hour

Nursing home residents might benefit from a new way of diagnosing and treating sepsis made possible by discoveries out of the University of British Columbia.